GBP1 and lung carcinoma: In addition, GBP1 is a single biomarker and could more easily be detected with IHC than with TMB, T-cell clonality, etc. To test the predictive effect of GBP1, we conducted GBP1 staining in tissue microarrays of patients with lung cancer who had been treated with immunotherapy.